[Translation] An open-label, multi-dose, dose-escalation Phase I clinical study to explore the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of NCR300 injection in the treatment of patients with higher-risk or relapsed/refractory myelodysplastic syndrome
探索NCR300注射液在骨髓增生异常综合征患者中的安全性和耐受性。 次要目的:评价NCR300注射液的药代动力学特征、药效动力学特征和在骨髓增生异常综合征患者中的初步有效性。
[Translation] To explore the safety and tolerability of NCR300 injection in patients with myelodysplastic syndrome. Secondary objective: To evaluate the pharmacokinetic and pharmacodynamic characteristics of NCR300 injection and its preliminary efficacy in patients with myelodysplastic syndrome.